| List | Section | Observation |
|---|---|---|
| PAHO Strategic Fund Medicine List | 11.1. Oxytocics | No observations |
| Bolivia | LINAME 2011 - 2013 | No observations |
| Cuba | 17.1.4 Citoprotectores | No observations |
| WHO Model List of Essential Medicines (2021) | 22.3 Uterotonics |
Others observations: − Management of incomplete abortion and miscarriage; − Prevention and treatment of postpartum haemorrhage where oxytocin is not available or cannot be safely used |
| List | Section | Observation |
|---|---|---|
| Cuba | 17.1.4 Citoprotectores | No observations |
| List | Section | Observation |
|---|---|---|
| Peru | 22.1 Oxytocins | No observations |
| WHO Model List of Essential Medicines (2021) | 22.3 Uterotonics |
Others observations: Only for use for induction of labour where appropriate facilities are available. |